Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 12, 2012, Pages 2976-2981

  Papadimitriou Olivgeris, Matthaios ^a   Marangos, Markos ^a   Fligou, Fotini ^a   Christofidou, Myrto ^a   Bartzavali, Christina ^a   Anastassiou, Evangelos D ^a   Filos, Kriton S ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Carriage; Critically ill patients; Resistance epidemiology; Surveillance

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE INHIBITOR; BORONIC ACID DERIVATIVE; CARBAPENEM DERIVATIVE; CARBAPENEMASE; IMIPENEM;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISK DIFFUSION; EPSILOMETER TEST; FEMALE; HODGE TEST; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INOCULATION; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RISK ASSESSMENT;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARRIER STATE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; RECTUM; RISK FACTORS;

EID: 84869442556     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks316     Document Type: Article

References (22)

1. Neuhauser MM, Weinstein RA, Rydman R et al. Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003; 289: 885-8.
2. Streit JM, Jones RN, Sader HS et al. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 2004; 24: 111-8.
3. Maltezou HC, Giakkoupi P, Maragos A et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect 2009; 58: 213-9.
4. Lledo W, Hernandez M, Lopez E et al. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR 2009; 58: 256-60.
5. Souli M, Galani I, Antoniadou A et al. An outbreak of infection due to b-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010; 50: 364-73.
6. Giakkoupi P, Papagiannitsis CC, Miriagou V et al. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10). J Antimicrob Chemother 2011; 66: 1510-3.
7. Grundmann H, Livermore DM, Giske CG et al. Carbapenemnon-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill 2010; 15: pii=19711.
8. Carbonne A, Thiolet JM, Fournier S et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill 2010; 15: pii=19734.
9. Schwaber MJ, Lev B, Israeli A et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011; 52: 848-55.
10. Schechner V, Kotlovsky T, Kazma M et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect 2012; doi:10.1111/j.1469-0691.2012.03888.x.
11. Borer A, Saidel-Odes L, Eskira S et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K. pneumoniae. Am J Infect Control 2012; 40: 421-5.
12. Tsakris A, Poulou A, Themeli-Digalaki K et al. Use of boronic acid disk tests to detect extended-spectrum b-lactamases in clinical isolates of KPC carbapenemase-possessing Enterobacteriaceae. J Clin Microbiol 2009; 47: 3420-6.
13. Queenan AM, Bush K. Carbapenemases: the versatile b-lactamases. Clin Microbiol Rev 2007; 20: 440-58.
14. Hyle EP, Ferraro MJ, Silver M et al. Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes. Infect Control Hosp Epidemiol 2010; 31: 1242-9.
15. Daikos GL, Vryonis E, Psichogiou M et al. Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallob-lactamase. J Antimicrob Chemother 2010; 65: 784-8.
16. Hussein K, Sprecher H, Mashiach Tet al. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009; 30: 666-71.
17. Falagas ME, Rafailidis PI, Kofteridis D et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother 2007; 60: 1124-30.
18. Jeon MH, Choi SH, Kwak YG et al. Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. Diagn Microbiol Infect Dis 2008; 62: 402-6.
19. Patel G, Huprikar S, Factor SH et al. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29: 1099-106.
20. Wiener-Well Y, Rudensky B, Yinnon AM et al. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. J Hosp Infect 2010; 74: 344-9.
21. Gasink LB, Edelstein PH, Lautenbach E et al. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009; 30: 1180-5.
22. Kontopidou F, Plachouras D, Papadomichelakis E et al. Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients. Clin Microbiol Infect 2011; 17: 9-11.